We have examined the interaction of factors in HeLa cell nuclear extracts with a human histone H2B gene (H2B) promoter. Protein-DNA mobility-shift and DNase I protection assays detected a factor(s) binding to a 15-base-pair consensus element that is essential for efficient H2B transcription in vitro. Part of this consensus sequence is the octanucleotide ATTTGCAT, which is apparently a functional component of several non-histone genes. A subset of these genes, including a human U2 small nuclear RNA (snRNA) gene promoter, a mouse immunoglobulin heavy chain enhancer, and a mouse light chain promoter, were shown to interact with the H2B consensus sequence-binding factor(s). These results suggest that a common factor or closely related factors may contribute to the regulation of these and other genes that share the octanucleotide sequence.
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Previous studies of a human histone H2B gene (H2B) promoter have identified a number of discrete functional elements, each of which is required for maximal levels of accurate transcription in nuclear extracts derived from HeLa cells (1) . These elements are localized between base pairs (bp) -118 and -21 (relative to a cap site) and include (in the 5' --3' direction) a region with two pairs of repetitive elements, a "CAAT" sequence, a hexamer sequence conserved among all human histone genes, an H2B-specific consensus sequence, and a "TATA" element (see Fig. 1 ). The H2B consensus sequence (CCTTATTTGCATAAG) extends from -53 to -39 and is conserved between H2B promoters in sea urchin, frog, chicken, and human (2) . This element is essential for efficient transcription of this gene; its removal by 5' deletion, linker-substitution, or point mutagenesis decreases transcription as much as 90% in vitro.
An essential part of this consensus sequence, the octamer ATTTGCAT, is found in a variety of non-histone genes. It is found in the same orientation in immunoglobulin K chain promoters (3) (4) (5) , in the putative promoter regions of several Drosophila melanogaster genes (6, 7) , and within the immunoglobulin heavy chain enhancer (8, 9) . It is found in inverted orientation in immunoglobulin heavy chain promoters (4, 5) , in human U2 (10, 11) and amphibian U2 (12) and U1 (13, 14) small nuclear RNA (snRNA) gene promoters, and (with one mismatch) in the simian virus 40 (SV40) enhancer (4) . The wide distribution of this sequence among a diverse set of genes and the lack of a fixed orientation or position relative to the transcription initiation sites suggested that the octamer might bind one or more transcription factor(s) (presumably protein) that can act in a variable manner.
To search for factors interacting with the H2B promoter, we have used protein-DNA mobility-shift and DNase I protection ("footprint") assays with nuclear extracts and chromatographic fractions derived from human HeLa cells. Our results show that the H2B consensus sequence binds a factor present in nuclear extracts and that an immunoglobulin light chain promoter, a heavy chain enhancer, and a U2 snRNA promoter specifically compete for this factor. These data suggest that a common factor, or a related group of factors, may recognize a consensus octamer in many genes.
MATERIALS AND METHODS
Enzymes. Restriction and DNA-modification enzymes were purchased from Bethesda Research Laboratories.
Plasmids. The H2B mutant plasmids used have been described (1) . All constructs were cloned in bacteriophage M13 mplO. The human U2 snRNA mutant plasmids have been described (10) and consisted of inserts extending from -198 or -256 to +442 cloned in pBR322. The mouse T1 K chain immunoglobulin 5'-deletion mutants, p90-gpt and p160-gpt (4), contained respectively 60 and 130 bp 5' to the cap site. EcoRI-Xba I fragments used in the competitions extended from the deletion endpoint to approximately +900. Immunoglobulin heavy chain enhancer plasmids comprised the adenovirus major late promoter extending from -51 to +192 cloned in pUC12, either with or without juxtaposition at -51 of a 1-kbp Xba I fragment containing the enhancer from a mouse Y2b (IgG2b heavy chain) gene (9) .
Mobility-Shift Assays. Nuclear extracts employed in these assays were prepared from HeLa cells synchronized to the S phase, as described in ref. 15 . Assays were a modification of the procedure described in ref. 16 competitor DNA for the -147/-162 complex was included in each reaction. After binding, samples were treated with DNase I (2 Ag/ml) for 1 min at 20TC. Digestion was stopped by the addition of 20 mM EDTA, and electrophoresis of complexes was performed as usual. Appropriate bands were excised from the gel and the DNA was electroeluted in 0.25x TBE at 50 mA. Recovered fragments were passed through a cotton plug to remove acrylamide, extracted with phenol/ chloroform (1:1) and chloroform, and precipitated with ethanol. DNA was electrophoresed in an 8% polyacrylamide/urea sequencing gel and visualized autoradiographically.
RESULTS

H2B Sequences
Interact with Factors in Nuclear Extracts. The initial objective was to determine whether H2B sequences interacted in a site-specific way with factors (presumably proteins) in HeLa cell-derived nuclear extracts and whether such interactions could be correlated with functional H2B promoter elements. These analyses employed an electrophoretic assay that exploits the high-affinity binding properties of site-specific DNA-binding proteins and results in a shift in the mobility of a labeled DNA fragment when the protein is bound. This assay has been used successfully to define site-specific protein-DNA interactions in several other genes (18) (19) (20) (21) . In the present case, a radioactively labeled H2B promoter fragment was incubated with nuclear extract in the presence of an excess of carrier DNA, which binds nonspecific DNA-binding proteins and facilitates resolution of specific DNA-protein complexes. Of the several bands seen in addition to that of the unbound DNA, those resulting from sequence-specific factor-DNA interactions were deduced by competition studies with unlabeled wild-type and mutant H2B promoter-containing plasmids.
Three major bands were apparent in the initial assays with a labeled H2B fragment extending from -162 to +20 (Fig. 1) . The pattern and band intensities seen with carrier DNA alone (data not shown) were exactly the same as those seen in the presence of an unlabeled H2B promoter-containing plasmid (5'A-39) lacking all promoter elements 5' to the TATA box (lane 6). In the case of band 1, the intensity was greatly reduced by all H2B plasmid competitors (indicated above the lanes) containing an intact H2B consensus sequence (-53 to -39); these included the wild-type competitor (lanes 1 and 7), 5' deletions to -147 (lane 8) and to -60 (lane 9), and a 3' deletion to -33 (lane 2). In contrast, no specific competition for band 1 was seen with competitors lacking an intact H2B consensus sequence; these included plasmids with a 5' deletion to -39 (lane 6), a 3' deletion to -53 (lane 10), a linker-substitution mutant replacing sequences between -53 and -39 (lane 3), and a double point mutation (see figure legend) in the H2B consensus octamer (lane 4). These results suggested that the complex in band 1 contained a factor that interacted specifically with the H2B consensus sequence.
The wild-type H2B competitor ( Fig. 1 , lanes 1 and 7) reduced (by a factor of 6) the level of band 2 relative to the level observed with competitors containing 5' deletions to -60 and to -39 (lanes 5, 6, and 9) or in the absence of specific competitor (data not shown, see above). The loss of competition with the deletion of 5' sequences to -147 (lane 8) indicates that the 5' boundary of the interaction site lies between -162 and -147, while effective competition with a 3' deletion mutant extending to -115 (data not shown) indicates that the 3' boundary lies upstream of this region. In agreement with these results, and clearly showing that the H2B consensus sequence is not involved in the interaction associated with band 2, competition was observed with the linker substitution (lane 3 The most rapidly migrating complex (indicated by band 3) was apparently due to interaction with a nonspecific DNAbinding protein, since its intensity was not significantly altered by competition with any specific template but could be strongly reduced by preincubation of the nuclear extract with unlabeled nonspecific competitor DNA (see Fig. 5 ). Although the experiments of Fig. 1 were conducted at a single competitor DNA concentration, the results of similar experiments with a broader range of competitor concentrations (see Fig. 1 legend) confirmed the above conclusions regarding bands 1-3.
Additional and more direct evidence for an interaction between a HeLa factor and the H2B consensus region was obtained using radioactively labeled fragments from two 5' H2B deletion mutants. One construction contained sequences from -60 to +230, including the H2B consensus sequence, while the other contained only sequences from -39 to +230 and thus lacked the consensus element. After incubation with nuclear extract, both labeled fragments generated several bands that migrated more slowly than the free DNA (Fig. 2) , but an extra band, B, was present in the assay using the -60 mutant. Further, the intensity of this band decreased when binding was assayed in the presence of plasmids containing the H2B consensus element, relative to the intensity seen with plasmids lacking an intact consensus region (data not shown). Band B therefore corresponded to the H2B consensus region-factor complex.
Band A in Fig. 2 corresponded to a complex requiring sequences between +100 and +230 for its formation, as demonstrated by competition analyses using various 5'-and 3-deletion mutants (data not shown). Bands C corresponded to non-H2B-specific DNA-protein complexes, since their intensities were reduced equally by specific and nonspecific competitor DNAs. Using a DNase I protection ("footprint") assay, we examined the region of DNA that was protected from nuclease digestion by the H2B consensus region-binding factor.
Factor-DNA complexes in the initial incubation mixture were treated with DNase I before electrophoresis. Subsequently, labeled bands corresponding to bound (band 1 in Fig. 1 ) and unbound DNA fragments were excised from the gel. After protein removal (see Materials and Methods) the DNase cleavage patterns of each population were examined. Fig. 3 Fig. 1 , and extending from -162 to +20, was 3' end-labeled at +20. DNase I protection analysis of DNA-factor complexes was as described in Materials and Methods. After nuclease digestion, purified DNA fragments were run in a sequencing gel alongside the same fragment cleaved at guanine residues (lane G). Numbers indicate G positions 5' to the H2B cap site. DNA isolated from the H2B consensus complex (bound) and unbound DNA are indicated. The protected region (-40 to -53) is shown by a bar, and the hypersensitive site (-56), which was more readily apparent at a lower autoradiographic exposure, is indicated by the arrowhead.
(see Fig. 4 ) and unequivocally confirmed the DNA binding specificity of the H2B consensus region-binding factor.
Immunoglobulin and U2 snRNA Genes Bind the H2B Consensus Region-Binding Factor(s). Since a variety of nonhistone genes contain the octamer sequence, we determined whether a subset of these genes could interact with the H2B consensus factor. Incubation/competition experiments were carried out with the labeled H2B promoter fragment used in Fig. 1 and with unlabeled human U2 snRNA promoter, mouse immunoglobulin heavy chain enhancer, and mouse K light chain immunoglobulin promoter competitors. A comparison of the octamer and flanking sequences in these genes is presented in Fig. 4 . To maximize potential competitor DNA-protein interactions, specific competitor and carrier DNAs were preincubated with nuclear extract before the addition of the labeled fragment. This protocol greatly decreased the intensity of band 3 (which we therefore deduce to be due to nonspecific DNA-protein interaction) but did not otherwise alter the positions or intensities of bands 1 and 2. Fig. 5a shows the results of competition with plasmids containing either of two 5' deletions of a human U2 snRNA gene. The mutant that contained 256 bp 5' to the cap site included the octamer homology, whereas in the -198 mutant this homology had been deleted. The deleted region has been shown (11, 12) to be essential for efficient transcription of this gene by Xenopus laevis oocyte injection and mammalian in vitro transcription assays. Although incubation with increasing concentrations of the two competitors decreased the intensity of all labeled complexes, the -256 mutant reduced the intensity of the band corresponding to the H2B consensus region-binding factor 3. (22), the human U2 snRNA gene described by Westin et al. (11) , the T1 K light chain immunoglobulin promoter (4), and the immunoglobulin heavy chain enhancer isolated from a clone containing the Y2b gene (9) . Sequences are written in the 5' to 3' direction, with the nontranscribed strand shown, unless otherwise noted. Numbers indicate nucleotide position relative to the cap site.
in the U2 promoter interacted with a factor(s) in the band 1 complex.
To address whether a mouse immunoglobulin K-chain promoter could stably interact with the H2B consensus region-binding factor, we used DNA fragments containing 130 or 60 bp of sequence 5' to the cap site in competition assays. Sequences between these points contain the consensus octanucleotide and are required for the B-cell-specific expression of this gene (3, 4) . Fig. 5b shows that the -130 mutant decreased the intensity of the H2B consensus band 3-fold more than equivalent amounts of the -60 mutant, suggesting that the octamer homology in this gene could bind to the H2B consensus region-binding factor(s).
Fig. Sc shows that a mouse immunoglobulin heavy chain enhancer, active primarily in cells of lymphoid lineages (9) , also competed effectively for the H2B consensus regionbinding factor. A plasmid containing the enhancer decreased the amount oflabeled complex 7-fold more than an equivalent amount of control plasmid.
DISCUSSION
Using DNA-protein mobility-shift and DNase I protection assays, we have shown that several regions of a cell cycleregulated human histone H2B gene interacted with factors in HeLa cell nuclear extracts. These included a region between -162 and -147 (bp relative to the cap site), a region between + 100 and +230, and an H2B consensus element centered at -45. Non-histone genes that contain homologies to this latter element could interact with the H2B consensus regionbinding factor(s), suggesting that a common transcription factor can bind to and may be used by these genes.
The significance of the complexes in the -162 to -115 and +100 to +230 regions remains unclear, since sequences in these regions are not required for maximal levels of transcription in vitro (1) . However, factors interacting with these regions might contribute to transcription efficiency in vivo or they might have some other function; for example, the coding region complex might contribute to mRNA stability.
The complex whose significance is most clear is that involving an H2B consensus element. This sequence is required for effective function of promoter elements that are further upstream; its perturbation reduces transcription as . Mobility-shift assays were performed with the labeled H2B promoter fragment described in Fig. 1 and with unlabeled specific competitors as detailed below and in Fig. 4 . Unlabeled competitor DNAs were preincubated with nuclear extract before addition of the labeled fragment. The amount of specific competitor is indicated above the appropriate lanes. The lower levels of competitors indicated in a, b, and c correspond respectively to 125-, 30-, and 100-fold molar excesses of competitor to labeled insert. Data shown here were part of more extensive titrations, extending over an 8-fold range of competitors, whose overall results were consistent with those shown here. Bands 1 and 2 are the same as designated in Fig. 1 much as 90% in vitro (1) . A discrete labeled DNA-factor complex was seen only in the presence of an intact H2B consensus element. The amount of labeled complex was greatly reduced by competitor DNAs that contained this element. Further, the identity of this complex was confirmed by "footprint" analysis showing that a region including the highly conserved octamer core of the H2B consensus sequence was protected from digestion by DNase I. Since functional promoter elements 5' or 3' to the consensus sequence were not required for interaction with the specific binding factor(s), and since the H2B consensus sequence was the only promoter sequence protected from DNase I digestion, we conclude that this complex contained a single factor.
The H2B consensus element shares at least 8 nucleotides with fuhctional elements in immunoglobulin promoters, heavy chain enhancers, and U2 snRNA promoters (Fig. 4) . Transcription of these promoters is regulated quite differently. The H2B promoter is preferentially transcribed during the S phase of the cell cycle (22) , immunoglobulin genes are transcribed exclusively in lymphoid tissues (3, 8, 9) , and U2 snRNA genes are apparently expressed in all tissues (reviewed in ref. 23) . It was therefore of great interest to determine whether these sequences could be recognized by a common factor in HeLa cell nuclear extracts. Using the gel shift/competition assay, we showed that a mouse heavy chain enhancer and those regions of a human U2 snRNA promoter and mouse light chain promoter containing the octamer effectively bound the H2B consensus region-binding factor(s).
There are several plausible interpretaftions of these data. The first is that a common factor interacts with the octamer element in all these genes and in all different cell types and thereby enhances their transcription. Such a factor could not be solely responsible for the lymphoid-specific or S phasepotentiated transcription of immunoglobulin or histone H2B genes but might contribute to their regulation through interactions with other more specific factors. For example, in the H2B promoter the octamer lies downstream of a histonespecific hexamer (see Fig. 1 ) that could bind a necessary cell cycle-regulatory factor (1). Second, a single protein factor may be posttranslationally modified in its non-DNA-binding domain(s) in a cell cycle-or tissue-specific way, so that its functional specificity would be altered. Third, there may exist a family of related proteins, differing in primary structure, with similar DNA binding specificity but with variable functional activities. Recently, a similar study (21) has demonstrated that a common factor(s) binds to the octamer element in both heavy and light chain immunoglobulin genes and in a heavy chain enhancer. It will require the purification of stimulatory factors that recognize the octamer in each of the genes in which it is a functional motif to determine whether these activities are interchangeable and how they contribute to the regulated transcription of these genes.
